Methamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons (Q44747866)

5 December 2017

Methamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons (English)

1 reference

5 December 2017

1 reference

8

Igor Grant

1 reference

5 December 2017

2

Robert K Heaton

1 reference

5 December 2017

5

David J Moore

1 reference

5 December 2017

4

Thomas D Marcotte

1 reference

5 December 2017

7

Tanya Wolfson

1 reference

5 December 2017

9

HNRC Group

1 reference

5 December 2017

1

Julie D Rippeth

1 reference

5 December 2017

Catherine L Carey

3

1 reference

PubMed ID

14751002

5 December 2017

Raul Gonzalez

series ordinal

6

1 reference

5 December 2017

1 January 2004

1 reference

Journal of the International Neuropsychological Society

5 December 2017

1 reference

5 December 2017

10

1 reference

5 December 2017

1

1 reference

5 December 2017

1-14

1 reference

Increased cerebral blood volume in HIV-positive patients detected by functional MRI.

5 December 2017

1 reference

https://api.crossref.org/works/10.1017%2FS1355617704101021

Progressive cerebral volume loss in human immunodeficiency virus infection: a longitudinal volumetric magnetic resonance imaging study. HIV Neurobehavioral Research Center Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617704101021

Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617704101021

Magnetic resonance imaging morphometric analysis of cerebral volume loss in human immunodeficiency virus infection. The HNRC Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617704101021

Abnormal cerebral perfusion in chronic methamphetamine abusers: a study using 99MTc-HMPAO and SPECT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617704101021

Methamphetamine-induced neurotoxicity: roles for glutamate and dopamine efflux

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617704101021

Cognitive performance of current methamphetamine and cocaine abusers

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617704101021

Cognitive impairment in individuals currently using methamphetamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617704101021

Prevalence of psychiatric disorders among men infected with human immunodeficiency virus. A controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617704101021

Neuronal apoptosis induced by HIV-1 gp120 and the chemokine SDF-1 alpha is mediated by the chemokine receptor CXCR4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617704101021

Methamphetamine-related psychiatric symptoms and reduced brain dopamine transporters studied with PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617704101021

Neuropsychological deficits in schizophrenics. Relationship to age, chronicity, and dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617704101021

Ischemic stroke associated with methamphetamine inhalation

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617704101021

HIV-1 Tat through phosphorylation of NMDA receptors potentiates glutamate excitotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617704101021

Paced auditory serial-addition task: a measure of recovery from concussion

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617704101021

Neuroscience research in AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617704101021

Evidence for early central nervous system involvement in the acquired immunodeficiency syndrome (AIDS) and other human immunodeficiency virus (HIV) infections. Studies with neuropsychologic testing and magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617704101021

Neurometabolic effects of psilocybin, 3,4-methylenedioxyethylamphetamine (MDE) and d-methamphetamine in healthy volunteers. A double-blind, placebo-controlled PET study with [18F]FDG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617704101021

Verbal memory performance of patients with human immunodeficiency virus infection: evidence of subcortical dysfunction. The HNRC Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617704101021

The role of glutamate in behavioral and neurotoxic effects of methamphetamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617704101021

Norms for letter and category fluency: demographic corrections for age, education, and ethnicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617704101021

Acceleration of HIV dementia with methamphetamine and cocaine

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617704101021

Attention and memory in illicit amphetamine users: comparison with non-drug-using controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617704101021

Non-injection substance use correlates with risky sex among men having sex with men: data from HIVNET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617704101021

Attention and memory in illicit amphetamine users

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617704101021

Incidence and prevalence of neurological disorders associated with HIV since the introduction of highly active antiretroviral therapy (HAART).

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617704101021

Potential time course of human immunodeficiency virus type 1-associated minor motor deficits: electrophysiologic and positron emission tomography findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617704101021

Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617704101021

The Paced Auditory Serial Addition Task (PASAT): norms for age, education, and ethnicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617704101021

Seminars in medicine of the Beth Israel Hospital, Boston. Dementia associated with the acquired immunodeficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617704101021

Higher cortical and lower subcortical metabolism in detoxified methamphetamine abusers

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617704101021

AIDS-associated mild neurocognitive impairment is delayed in the era of highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617704101021

Methamphetamine neurotoxicity: necrotic and apoptotic mechanisms and relevance to human abuse and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617704101021

HIV-associated neurologic disease incidence changes:: Multicenter AIDS Cohort Study, 1990-1998

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617704101021

Evidence for long-term neurotoxicity associated with methamphetamine abuse: A 1H MRS study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617704101021

A DISTRIBUTION-FREE k-SAMPLE TEST AGAINST ORDERED ALTERNATIVES

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617704101021

7 January 2021

Neuronal damage of the substantia nigra in HIV-1 infected brains

1 reference

https://api.crossref.org/works/10.1017%2FS1355617704101021

7 January 2021

Regional cerebral blood flow in cocaine- versus methamphetamine-dependent patients with a history of alcoholism.

1 reference

https://api.crossref.org/works/10.1017%2FS1355617704101021

7 January 2021

Cerebral Vascular Changes Secondary to Amphetamine Abuse in the Experimental Animal

1 reference

https://api.crossref.org/works/10.1017%2FS1355617704101021

7 January 2021

The HNRC 500--neuropsychology of HIV infection at different disease stages. HIV Neurobehavioral Research Center.

1 reference

https://api.crossref.org/works/10.1017%2FS1355617704101021

7 January 2021

Nigral degeneration in acquired immune deficiency syndrome (AIDS)

1 reference

https://api.crossref.org/works/10.1017%2FS1355617704101021

7 January 2021

Neuropsychological performance in HIV-1-infected drug abusers.

1 reference

https://api.crossref.org/works/10.1017%2FS1355617704101021

7 January 2021

Striatal dopamine nerve terminal markers in human, chronic methamphetamine users

1 reference

https://api.crossref.org/works/10.1017%2FS1355617704101021

7 January 2021

Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users: evidence from positron emission tomography studies with [11C]WIN-35,428.

1 reference

https://api.crossref.org/works/10.1017%2FS1355617704101021

7 January 2021

Predictors of neuropsychological performance in HIV positive women

1 reference

https://api.crossref.org/works/10.1017%2FS1355617704101021

7 January 2021

Neuropsychological studies of asymptomatic human immunodeficiency virus-type-1 infected individuals. The HNRC Group. HIV Neurobehavioral Research Center

1 reference

https://api.crossref.org/works/10.1017%2FS1355617704101021

7 January 2021

Changes to AIDS dementia complex in the era of highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1017%2FS1355617704101021

7 January 2021

Dopamine-glutamate interactions in methamphetamine-induced neurotoxicity

1 reference

https://api.crossref.org/works/10.1017%2FS1355617704101021

7 January 2021

10.1017/S1355617704101021

Identifiers

DOI

0 references

PubMed ID

14751002

1 reference

PubMed ID

14751002